181 related articles for article (PubMed ID: 26556943)
1. Assessing the Practices of Population-Based Birth Defects Surveillance Programs Using the CDC Strategic Framework, 2012.
Mai CT; Correa A; Kirby RS; Rosenberg D; Petros M; Fagen MC
Public Health Rep; 2015; 130(6):722-30. PubMed ID: 26556943
[TBL] [Abstract][Full Text] [Related]
2. Development and implementation of the first national data quality standards for population-based birth defects surveillance programs in the United States.
Anderka M; Mai CT; Romitti PA; Copeland G; Isenburg J; Feldkamp ML; Krikov S; Rickard R; Olney RS; Canfield MA; Stanton C; Mosley B; Kirby RS
BMC Public Health; 2015 Sep; 15():925. PubMed ID: 26386816
[TBL] [Abstract][Full Text] [Related]
3. Public Health Practice of Population-Based Birth Defects Surveillance Programs in the United States.
Mai CT; Kirby RS; Correa A; Rosenberg D; Petros M; Fagen MC
J Public Health Manag Pract; 2016; 22(3):E1-8. PubMed ID: 25905668
[TBL] [Abstract][Full Text] [Related]
4. Status of population-based birth defects surveillance programs before and after the Zika public health response in the United States.
Anderka M; Mai CT; M Judson E; Langlois PH; Lupo PJ; Hauser K; Salemi JL; Correia J; A Canfield M; Kirby RS;
Birth Defects Res; 2018 Nov; 110(19):1388-1394. PubMed ID: 30230268
[TBL] [Abstract][Full Text] [Related]
5. Clinician reviewers in birth defects surveillance programs: survey of the National Birth Defects Prevention Network.
Lin AE; Forrester MB; Cunniff C; Higgins CA; Anderka M
Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):781-6. PubMed ID: 17051528
[TBL] [Abstract][Full Text] [Related]
6. Geocoding capacity of birth defects surveillance programs: results from the National Birth Defects Prevention Network Geocoding Survey.
Wang Y; O'Leary LA; Rickard RS; Mason CA;
J Registry Manag; 2010; 37(1):22-6. PubMed ID: 20795566
[TBL] [Abstract][Full Text] [Related]
7. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
8. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention.
Correa-Villaseñor A; Cragan J; Kucik J; O'Leary L; Siffel C; Williams L
Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):617-24. PubMed ID: 14703783
[TBL] [Abstract][Full Text] [Related]
9. Birth defects interstate data exchange: a battle worth fighting?
Cassell C; Mai C; Rickard R
Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):806-10. PubMed ID: 17990342
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Difficult Decisions in Public Health Surveillance: Striking the Right Balance between Timeliness and Completeness.
Salemi JL; Tanner JP; Anjohrin SB; Rutkowski RE; Correia JA; Watkins SM; Kirby RS
J Registry Manag; 2015; 42(2):48-61. PubMed ID: 26360106
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of congenital malformations surveillance in New York State: an application of Centers for Disease Control and Prevention (CDC) guidelines for evaluating surveillance systems.
Sekhobo JP; Druschel CM
Public Health Rep; 2001; 116(4):296-305. PubMed ID: 12037258
[TBL] [Abstract][Full Text] [Related]
12. Registry to referral: using birth defects registries to refer infants and toddlers for early intervention services.
Farel AM; Meyer RE; Hicken M; Edmonds LD
Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):647-50. PubMed ID: 14703788
[TBL] [Abstract][Full Text] [Related]
13. Collection, use, and protection of population-based birth defects surveillance data in the united states.
Mai CT; Law DJ; Mason CA; McDowell BD; Meyer RE; Musa D;
Birth Defects Res A Clin Mol Teratol; 2007 Dec; 79(12):811-4. PubMed ID: 18064713
[TBL] [Abstract][Full Text] [Related]
14. Public health surveillance data: legal, policy, ethical, regulatory, and practical issues.
Bernstein AB; Sweeney MH;
MMWR Suppl; 2012 Jul; 61(3):30-4. PubMed ID: 22832995
[TBL] [Abstract][Full Text] [Related]
15. The relative contribution of data sources to a birth defects registry utilizing passive multisource ascertainment methods: does a smaller birth defects case ascertainment net lead to overall or disproportionate loss?
Salemi JL; Tanner JP; Block S; Bailey M; Correia JA; Watkins SM; Kirby RS
J Registry Manag; 2011; 38(1):30-8. PubMed ID: 22097703
[TBL] [Abstract][Full Text] [Related]
16. Hospital discharge data: can it serve as the sole source of case ascertainment for population-based birth defects surveillance programs?
Wang Y; Cross PK; Druschel CM
J Public Health Manag Pract; 2010; 16(3):245-51. PubMed ID: 20357611
[TBL] [Abstract][Full Text] [Related]
17. Methodological issues in setting up a surveillance system for birth defects in India.
Suresh S; Thangavel G; Sujatha J; Indrani S
Natl Med J India; 2005; 18(5):259-62. PubMed ID: 16433142
[TBL] [Abstract][Full Text] [Related]
18. Developing a database management system to support birth defects surveillance in Florida.
Salemi JL; Hauser KW; Tanner JP; Sampat D; Correia JA; Watkins SM; Kirby RS
J Registry Manag; 2010; 37(1):10-5; quiz 38-9. PubMed ID: 20795564
[TBL] [Abstract][Full Text] [Related]
19. Improving integration and coordination of funding, technical assistance, and reporting/data collection: recommendations from CDC and USAPI stakeholders.
Ka'opua LS; White SF; Rochester PF; Holden DJ
Pac Health Dialog; 2011 Mar; 17(1):185-97. PubMed ID: 23008984
[TBL] [Abstract][Full Text] [Related]
20. Sources of variability in birth defects prevalence rates.
Hobbs CA; Hopkins SE; Simmons CJ
Teratology; 2001; 64 Suppl 1():S8-S13. PubMed ID: 11745838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
